Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug:56:118-126.
doi: 10.1016/j.mib.2020.09.001. Epub 2020 Nov 2.

Microbiome in cancer progression and therapy

Affiliations
Review

Microbiome in cancer progression and therapy

Natalia V Andreeva et al. Curr Opin Microbiol. 2020 Aug.

Abstract

A myriad of microbes living together with the host constitute microbiota, which possesses very diverse functions in regulation of host physiology. Recently, it has been unequivocally demonstrated that microbiota regulates cancer initiation, progression and responses to therapy. Here we review known pro-tumorigenic and anti-tumorigenic function of microbiota and mechanisms how microbes can regulate cancer cells and immune and stromal cells within the tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Declarations of Interest: none

Figures

Figure 1
Figure 1. Roles of «beneficial» and «pathogenic» bacteria in primary tumor development and metastasis
Microbiota contains multiple species with different metabolic activities and other properties, and these species co-exist with the host within the particular niche or tissue. Each relevant bacterial species plays the different role in the primary tumor growth, metastasis and anti-cancer therapy. «Beneficial» bacteria can suppress tumor growth and improve anti-cancer therapies through several direct mechanisms but also can inhibit overgrowth and outcompete «pathogenic» bacteria in the context of cancer. Pathogenic bacteria promote tumor development, metastasis and resistance to therapies. “Green” reflects anti-tumorigenic action, while “Red” is tumor-promoting function. Arrows illustrate active promotion, while blocks illustrate inhibition. Figure was produced using BioRender platform.
Figure 2
Figure 2. Mechanisms of microbiota-host interactions promoting tumorigenesis
Non-modifiable (genetic) and environmental factors promote intestinal epithelial barrier disruption and dysbiosis. Barrier dysfunction causes bacterial penetration through the epithelium and their interaction with host cells by several mechanisms: (1) immune cell activation and triggering of pro-tumorigenic inflammation; (2) Epithelial cell DNA damage by bacterial toxins or bacteria-induced genotoxic products (e.g. ROS) ; (3) modulation of immune, stromal and cancer cell function through the effect of bacterial metabolites acting locally or distantly. Figure was produced using BioRender platform.

Similar articles

Cited by

References

    1. Tran HQ, Ley RE, Gewirtz AT, Chassaing B: Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases. Nat Commun 2019, 10:5650. - PMC - PubMed
    1. Koh JH, Kim WU: Dysregulation of gut microbiota and chronic inflammatory disease: from epithelial defense to host immunity. Exp Mol Med 2017, 49:e337. - PMC - PubMed
    1. Chittim CL, Martinez Del Campo A, Balskus EP: Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline. Nat Microbiol 2019, 4:155–163. - PubMed
    1. Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, Badger JH, Vats R, Sundd P, Tang HY, et al.: An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. Immunity 2018, 49:943–957 e949. - PMC - PubMed
    1. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K: Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 2014, 34:15490–15496. - PMC - PubMed

Publication types